Moderna
MRNA
#221
Rank
HK$806.49 B
Marketcap
HK$1,993
Share price
5.27%
Change (1 day)
935.17%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2026 (TTM): -HK$23.82 Billion

According to Moderna 's latest financial reports the company's current earnings are HK$2.21 Billion. In 2025 the company made an earning of -HK$21.63 Billion, an increase over its 2024 earnings that were of -HK$28.1 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$23.82 Billion10.12%
2025 -HK$21.63 Billion-23.03%
2024 -HK$28.1 Billion-8.22%
2023 -HK$30.62 Billion-140.65%
2022 HK$75.30 B-27.81%
2021 HK$104.31 B-1911.15%
2020 -HK$5.76 Billion44.7%
2019 -HK$3.99 Billion28.63%
2018 -HK$3.1 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$146.79 B-714.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$99.13 B-515.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
HK$60.30 B-352.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-HK$0.38 Billion-98.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-HK$0.93 Billion-96.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-HK$0.33 Billion-98.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$9.57 B-140.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-HK$1.26 Billion-94.76%๐Ÿ‡บ๐Ÿ‡ธ USA